The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II multicenter study of stereotactic radiotherapy (SRT) for oligoprogression in metastatic renal cell cancer (mRCC) patients receiving tyrosine kinase inhibitor (TKI) therapy.
 
Patrick Cheung
Research Funding - Abbvie (Inst); Pfizer (Inst); Sanofi (Inst); TerSera (Inst)
 
Samir Patel
No Relationships to Disclose
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen Oncology; Merck; Pfizer; Roche Canada; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis Canada Pharmaceuticals Inc (Inst); Roche Canada (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca
 
Arjun Sahgal
Leadership - Elekta; Elekta
Honoraria - Abbvie; BrainLAB; Elekta; Elekta; Varian Medical Systems
Consulting or Advisory Role - Abbvie; BrainLAB; Elekta; Merck; Roche; Varian Medical Systems; VieCure
Research Funding - Elekta (Inst); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Clustering software for Gamma Knife treatment planning (Inst)
Travel, Accommodations, Expenses - BrainLAB; Elekta; Varian Medical Systems
Other Relationship - Accuray; BrainLAB; Elekta; Elekta; Elekta; Elekta; Elekta MRL Consortium; International Stereotactic Radiosurgery Society; Medtronic; Varian Medical Systems
 
William Chu
No Relationships to Disclose
 
Hany Soliman
No Relationships to Disclose
 
Belal Ahmad
Consulting or Advisory Role - Abbvie; Ferring
 
Eric Winquist
Honoraria - Amgen; Bayer; Eisai; Merck; Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Francois Patenaude
No Relationships to Disclose
 
Tamim Niazi
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Sanofi; Tersera
Consulting or Advisory Role - Abbvie; Bayer; Janssen Oncology; Sanofi; Tersera
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Sanofi (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Gerald Lim
No Relationships to Disclose
 
Arbind Dubey
Consulting or Advisory Role - Bayer
 
Piotr Czaykowski
Research Funding - Clovis Oncology (Inst); Janssen Research & Development (Inst); Merck (Inst); Merck Sharp & Dohme (Inst)
 
Rebecca Wong
No Relationships to Disclose
 
Anand Swaminath
No Relationships to Disclose
 
Scott Carlyle Morgan
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
 
Justin White
No Relationships to Disclose
 
Sareh Keshavarzi
No Relationships to Disclose
 
Georg A. Bjarnason
Stock and Other Ownership Interests - Merck
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Research Funding - Merck (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer